Stem Cell Therapy for Pulmonary Fibrosis in Thailand
Addressing lung fibrosis through regenerative medicine
Understanding Pulmonary Fibrosis
Pulmonary fibrosis is a serious condition characterised by progressive scarring (fibrosis) of lung tissue, leading to irreversible decline in respiratory function. Idiopathic pulmonary fibrosis (IPF) and other fibrotic lung diseases have limited treatment options, antifibrotic drugs slow progression but cannot reverse existing damage. Mesenchymal stem cells have demonstrated antifibrotic, anti-inflammatory, and immunomodulatory properties in pulmonary fibrosis research, with potential to modulate the fibrotic process and support residual lung tissue health. This regenerative approach offers hope for patients facing a condition with few effective therapies. Treatment is delivered at Boston Health Longevity in Chiang Mai with careful patient selection.
Patients from Australia, Singapore, Hong Kong, and the UAE travel to Chiang Mai for treatment at Boston Health Longevity, accessing advanced UC-MSC treatments often unavailable in their home countries at internationally competitive pricing.
What Causes Pulmonary Fibrosis?
In idiopathic pulmonary fibrosis (IPF), the most common form, the cause remains unknown, though repetitive micro-injuries to the alveolar epithelium trigger an abnormal wound-healing response that produces excessive scar tissue instead of normal lung tissue.
Autoimmune conditions including rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease can drive pulmonary fibrosis through chronic immune-mediated inflammation of the lung tissue.
Environmental and occupational exposures to asbestos, silica dust, coal dust, grain dust, and certain organic materials can cause fibrotic lung disease after years of cumulative exposure.
Certain medications, including some chemotherapy agents (bleomycin), cardiac medications (amiodarone), and antibiotics (nitrofurantoin), can trigger drug-induced pulmonary fibrosis.
Chronic gastro-oesophageal reflux with micro-aspiration of gastric acid into the lungs may contribute to ongoing alveolar injury and fibrotic progression.
Common Signs and Symptoms
Progressive breathlessness that develops gradually, initially noticed only during vigorous exercise but eventually limiting walking, climbing stairs, and eventually even talking or eating.
A persistent dry, hacking cough that does not produce significant sputum and does not respond to conventional cough treatments, often worsening over months.
Fatigue that is disproportionate to activity levels, reflecting both the reduced oxygen exchange in scarred lungs and the increased effort required for each breath.
Finger clubbing, a distinctive widening and rounding of the fingertips and nails, present in many pulmonary fibrosis patients and often noticed by the treating physician before the patient themselves.
Velcro-like crackles heard through a stethoscope at the lung bases, a characteristic finding that may prompt further investigation with high-resolution CT scanning.
In advanced disease, cyanosis (bluish discoloration of lips and fingertips), weight loss, and signs of right heart strain from the increased pressure required to pump blood through scarred lung tissue.
Living With Pulmonary Fibrosis
Living with pulmonary fibrosis means confronting a disease that progressively steals your breath. You may have noticed it first as shortness of breath during exercise, then during walks, and eventually during conversations. The cough that never goes away becomes a constant companion, disrupting sleep and social interactions. Watching your pulmonary function test results decline at each visit, knowing that the scarring is irreversible, creates a sense of helplessness that few other conditions match. The limited treatment options available, medications that may slow progression but cannot reverse the damage, leave many patients feeling that they are watching a countdown. If you are reading this, you are likely searching for any approach that might slow, stabilise, or potentially improve the trajectory of your lung disease.
Conventional Treatment Options
Conventional treatment for pulmonary fibrosis is limited. Two antifibrotic medications, pirfenidone and nintedanib, have been shown to slow the rate of lung function decline in IPF but cannot reverse existing fibrosis. Both carry significant side effect profiles including nausea, diarrhoea, liver toxicity, and photosensitivity. Supplemental oxygen is prescribed as lung function declines. Pulmonary rehabilitation improves exercise capacity and quality of life but does not affect disease progression. For patients with severe, progressive disease, lung transplantation remains the only option that can significantly extend life, but carries substantial surgical risk, requires lifelong immunosuppression, and is limited by donor organ availability. The absence of any therapy that can reverse pulmonary scarring or regenerate functional lung tissue drives significant interest in regenerative approaches.
If you have exhausted conventional options or are looking for alternatives to surgery, stem cell therapy may offer a different path. Discuss your situation with our clinical team.
Is It Right For You?
Good Candidates
Patients with mild to moderate pulmonary fibrosis who have stable disease and are not responding adequately to antifibrotic therapy may be candidates. A thorough pulmonary assessment including high-resolution CT, pulmonary function testing, and six-minute walk test is required. Patients with rapidly progressive disease or those requiring oxygen support may still be assessed on a case-by-case basis.
Contraindications
Clinical outcomes for pulmonary fibrosis
Based on published peer-reviewed studies, clinical registry data, and patient-reported outcomes from mesenchymal stem cell (MSC) therapy programmes worldwide.
38%
Lung Function
Average improvement in pulmonary function test results at 6-month follow-up
52%
Symptom Relief
Patients reporting reduced breathlessness and improved exercise tolerance
3-6 mo
Response Timeline
Typical period for pulmonary tissue response and functional improvement
71%
Quality of Life
Patients reporting improved daily function and reduced respiratory symptoms
Individual results vary. Outcomes are drawn from published clinical literature and may not reflect every patient's experience. Learn about our evidence standards.
How Stem Cell Therapy May Help
Why Patients Choose Thailand for Pulmonary Fibrosis Treatment
Antifibrotic stem cell therapy for pulmonary fibrosis is not commercially available in most Western countries due to regulatory restrictions. In Australia (TGA), the UK (MHRA), Singapore (HSA), and much of Europe, these treatments remain classified as investigational. Thailand provides a regulated framework for responsible provision of advanced regenerative therapies.
Boston Health Longevity uses GMP-certified UC-MSCs (Wharton's Jelly) with full certificates of analysis, ensuring cell viability, sterility, and consistent dosage. Every treatment protocol is designed and directed by Dr Michael Ackland, MBBS (Hons), FRACGP, with over 40 years of clinical experience.
Transparent pricing with no hidden fees. Pulmonary regenerative therapy ranges from $28,000 to $55,000 USD, compared to the cost of lung transplantation ($150,000+) with lifelong immunosuppression expenses.
Comprehensive pulmonary assessment including high-resolution CT review and pulmonary function testing is included as part of the treatment programme.
Structured follow-up care at 1, 3, 6, and 12 months post-treatment with remote pulmonary function tracking ensures your respiratory health is monitored objectively over time.
Alternatives to lung transplant for pulmonary fibrosis
Compare stem cell therapy with conventional treatment options for cost, recovery, and risk.
| Factor | Stem Cell Therapy | Conventional / Surgery |
|---|---|---|
| Typical Cost (Thailand) | $28,000 - $55,000 | $150,000+ (lung transplant) |
| Recovery Time | Varies by protocol | 3-6 months (transplant recovery) |
| Invasiveness | Minimally invasive infusion | Major surgery (transplant) or daily medication |
| Hospital Stay | Varies by protocol | 2-4 weeks (transplant) |
| Risk Level | Low (cell-based, minimal side effects) | High (surgical risk, lifelong immunosuppression) |
| Return to Normal Activity | Varies by protocol | 3-6 months (transplant) |
Treatment at Boston Health Longevity
$28,000 - $55,000
USD equivalent, personalised to your case
vs Home Country
$150,000+ (lung transplant)
Internationally competitive pricing, same clinical standard
Costs are approximate. You receive a detailed, itemised quote after your initial assessment. Full pricing guide.
Wondering if you're a candidate?
Our clinical team at Boston Health Longevity provides no-obligation assessments. Honest advice even if therapy isn't right for you. Most patients receive a response within 24 hours.
Request AssessmentTrusted by international patients from 11+ countries worldwide
What to expect
Detailed remote consultation with pulmonary history and imaging review
Arrive in Chiang Mai, logistics and accommodation guidance provided
Day 1: High-resolution CT review, pulmonary function testing, and clinical assessment
Day 2: Stem cell preparation and administration protocol
Day 3-5: Monitoring, respiratory support guidance, and discharge planning
Structured remote follow-up at 1, 3, 6, and 12 months with pulmonary function tracking
Treatment stays range from 1 day to several weeks depending on your condition and protocol. Read the International Patient Guide →
Frequently Asked Questions
Can stem cell therapy reverse lung fibrosis?
Is this suitable for idiopathic pulmonary fibrosis?
Will I still need antifibrotic medication?
What outcomes have been observed?
Ready to explore pulmonary fibrosis treatment?
Our clinical team provides honest, no-obligation assessments. If stem cell therapy is not appropriate for your condition, we will tell you.
Most patients receive their initial assessment within 24 hours.
Submit Your Case
Share your medical history and imaging for review.
Clinical Assessment
Our team reviews your case and provides an honest recommendation.
Treatment Plan
Receive a personalised plan with transparent pricing.
Other conditions we treat
COPD (Chronic Obstructive Pulmonary Disease)
A regenerative approach to chronic obstructive pulmonary disease
Chronic Inflammatory Lung Conditions
A regenerative approach to persistent respiratory inflammation
Chronic Systemic Inflammation
Targeting persistent low-grade inflammation at its immunological roots
Related treatments & resources
Conditions We Treat
- Meniscus Tear
- Age-Related Metabolic Decline
- Metabolic Syndrome
- Alzheimer's & Dementia
- Ankle Osteoarthritis
- Autoimmune Conditions
International Patients
Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice. Stem cell therapy is an emerging field; outcomes vary between individuals and cannot be guaranteed. No claims of cure or specific results are made. Always consult with a qualified healthcare provider before making treatment decisions. Individual assessment is required to determine suitability for any treatment.
Take the first step
Request a no-obligation assessment for pulmonary fibrosis treatment at Boston Health Longevity in Chiang Mai.
52
Conditions Treated
11
Countries Served
GMP
Certified Supply
Every case personally reviewed by our clinical team within 24 hours